Henry Schein Inc.

76.50+1.08+1.43%Vol 202.77K1Y Perf -0.15%
Aug 10th, 2022 00:38 DELAYED
BID76.48 ASK76.52
Open75.94 Previous Close75.42
Pre-Market- After-Market-
 - -%  - -
Target Price
86.44 
Analyst Rating
Hold 2.83
Potential %
13.02 
Finscreener Ranking
★+     43.72
Insiders Trans % 3/6/12 mo.
-100/-88/-89 
Value Ranking
★★+     48.02
Insiders Value % 3/6/12 mo.
-100/-99/-99 
Growth Ranking
★★★     52.04
Insiders Shares Cnt. % 3/6/12 mo.
-100/-99/-99 
Income Ranking
 —    -
Price Range Ratio 52W %
27.86 
Earnings Rating
Sell
Market Cap10.41B 
Earnings Date
2nd Aug 2022
Alpha-0.01 Standard Deviation0.08
Beta0.74 

Today's Price Range

75.6676.52

52W Range

70.2592.68

5 Year PE Ratio Range

9.0029.60

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
1.18%
1 Month
-1.90%
3 Months
-10.81%
6 Months
-1.14%
1 Year
-0.15%
3 Years
19.66%
5 Years
-9.85%
10 Years
95.49%

TickerPriceChg.Chg.%
HSIC76.501.08001.43
AAPL168.243.32002.01
GOOG120.923.42002.91
MSFT288.065.76002.04
XOM91.330.73830.81
WFC44.551.14502.64
JNJ170.09-0.0899-0.05
FB196.640.99000.51
GE77.122.19002.92
JPM118.443.06002.65
 
ProfitabilityValueIndustryS&P 500US Markets
29.70
6.90
8.60
5.90
5.26
RevenueValueIndustryS&P 500US Markets
9.69B
70.18
2.27
-1.29
Earnings HistoryEstimateReportedSurprise %
Q02 20221.121.163.57
Q01 20221.211.307.44
Q04 20210.901.0718.89
Q03 20210.941.1017.02
Q02 20210.951.1116.84
Q01 20210.831.2449.40
Q04 20200.961.004.17
Q03 20200.721.0343.06
Earnings Per EndEstimateRevision %Trend
6/2022 QR1.12-2.61Negative
9/2022 QR1.18-3.28Negative
12/2022 FY4.860.00-
12/2023 FY5.220.00-
Next Report Date-
Estimated EPS Next Report1.12
Estimates Count8
EPS Growth Next 5 Years %11.70
Volume Overview
Volume202.77K
Shares Outstanding136.11K
Shares Float121.71M
Trades Count5.35K
Dollar Volume15.44M
Avg. Volume843.48K
Avg. Weekly Volume964.67K
Avg. Monthly Volume771.78K
Avg. Quarterly Volume794.00K

Henry Schein Inc. (NASDAQ: HSIC) stock closed at 75.42 per share at the end of the most recent trading day (a -1.21% change compared to the prior day closing price) with a volume of 700.15K shares and market capitalization of 10.41B. Is a component of S&P 500, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Distribution industry, Healthcare sector and employs 21000 people. Henry Schein Inc. CEO is Stanley M. Bergman.

The one-year performance of Henry Schein Inc. stock is -0.15%, while year-to-date (YTD) performance is -2.72%. HSIC stock has a five-year performance of -9.85%. Its 52-week range is between 70.25 and 92.68, which gives HSIC stock a 52-week price range ratio of 27.86%

Henry Schein Inc. currently has a PE ratio of 16.60, a price-to-book (PB) ratio of 2.94, a price-to-sale (PS) ratio of 1.09, a price to cashflow ratio of 14.60, a PEG ratio of 2.32, a ROA of 8.18%, a ROC of 14.46% and a ROE of 19.11%. The company’s profit margin is 5.26%, its EBITDA margin is 8.60%, and its revenue ttm is $9.69 Billion , which makes it $70.18 revenue per share.

Of the last four earnings reports from Henry Schein Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.12 for the next earnings report. Henry Schein Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Henry Schein Inc. is Hold (2.83), with a target price of $86.44, which is +13.02% compared to the current price. The earnings rating for Henry Schein Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Henry Schein Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Henry Schein Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 7.78, ATR14 : 1.92, CCI20 : -47.89, Chaikin Money Flow : 0.00, MACD : -0.64, Money Flow Index : 41.76, ROC : -2.10, RSI : 36.12, STOCH (14,3) : 33.94, STOCH RSI : 0.77, UO : 40.52, Williams %R : -66.06), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Henry Schein Inc. in the last 12-months were: Gerald A. Benjamin (Sold 22 978 shares of value $1 963 930 ), James P. Breslawski (Sold 14 816 shares of value $1 280 129 ), Kurt P. Kuehn (Sold 2 200 shares of value $189 134 ), Mark E. Mlotek (Sold 30 367 shares of value $2 541 496 ), Michael S. Ettinger (Sold 21 112 shares of value $1 788 046 ), Philip A. Laskawy (Sold 2 790 shares of value $245 297 ), Scott P. Serota (Buy at a value of $85 870), Stanley M. Bergman (Sold 60 000 shares of value $4 754 357 ), Walter Siegel (Sold 30 140 shares of value $2 500 714 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (20.00 %)
2 (22.22 %)
2 (25.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
6 (60.00 %)
5 (55.56 %)
4 (50.00 %)
Moderate Sell
1 (10.00 %)
1 (11.11 %)
1 (12.50 %)
Strong Sell
1 (10.00 %)
1 (11.11 %)
1 (12.50 %)
Summary RatingHold
2.83
Hold
2.81
Hold
2.79

Henry Schein Inc.

Henry Schein is the largest wholesaler of dental and medical products to office-based practitioners. The company has been established for approximately 90 years and operates across nearly 30 distribution centers to offer hundreds of thousands of products to customers globally. Henry Schein also offers practice management products that include software products, technical, financial, and educational services. The company recently spun off its animal health business.

CEO: Stanley M. Bergman

Telephone: +1 631 843-5500

Address: 135 Duryea Road, Melville 11747, NY, US

Number of employees: 21 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

61%39%

Bearish Bullish

55%45%

Bearish Bullish

60%40%

TipRanks News for HSIC

Tue, 17 May 2022 09:01 GMT Analysts Offer Insights on Healthcare Companies: Syros Pharmaceuticals (SYRS), Henry Schein (HSIC) and Roche Holding AG (OtherRHHVF)

- TipRanks. All rights reserved.

Sun, 17 Apr 2022 12:47 GMT Henry Schein (HSIC) Receives a Buy from Robert W. Baird

- TipRanks. All rights reserved.

Wed, 23 Mar 2022 12:37 GMT Robert W. Baird Believes Henry Schein (HSIC) Wont Stop Here

- TipRanks. All rights reserved.

Wed, 16 Feb 2022 13:45 GMT Henry Schein (HSIC) Gets a Buy Rating from Barrington

- TipRanks. All rights reserved.

Tue, 15 Feb 2022 14:44 GMT Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Henry Schein (HSIC) and Applied Genetic Technologies (AGTC)

- TipRanks. All rights reserved.

News

Stocktwits